Low Dose Naltrexone (LDN) Across The Longevity Spectrum

Low Dose Naltrexone (LDN) Across The Longevity Spectrum

Brand: ldnrtevents
20.00 USD In stock Buy at Merchant

Watch the 60-minute live presentation followed by Q&A Sajad Zalzala, M.D. Founder & Longevity Physician Root Causes Medical Consultants | HealthTech Builder Education & Early Career Sajad Zalzala earned his Bachelor’s degrees in Computer Science and Biological Sciences before completing his Doctor of Medicine at Wayne State University School of Medicine. Board-certified by the American Board of Family Medicine, he began his career in primary care, where he developed a strong interest in prevention, systems-based medicine, and early intervention. His background in both technology and clinical medicine positioned him to work at the intersection of healthcare delivery and digital innovation. Expertise in Longevity & Telehealth Innovation In 2017, Dr Zalzala founded Root Causes Medical Consultants, a telehealth platform focused on functional and longevity medicine. He later co-founded AgelessRx, serving as Chief Medical Officer and helping build one of the first national telemedicine platforms dedicated to longevity therapeutics. His clinical focus includes multi-driver ageing optimisation, metabolic and immune health, and the evidence-based use of repurposed therapeutics such as low-dose naltrexone and rapamycin. Leadership & Industry Impact Licensed in all 50 U.S. states, Dr Zalzala has led national clinical strategy, decentralised longevity trials, and regulatory initiatives across multiple digital health platforms. He has authored peer-reviewed publications in geroscience and ageing research and is a frequent speaker at medical and longevity conferences. Through scalable telehealth systems and data-driven clinical frameworks, he continues to advance precision longevity medicine and expand access to preventive, science-based ageing interventions.

Variants (1)
  • Default Title — 20.00 USD — In stock

AI Readiness

Good foundation, but some important product data is still missing.

66%